A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices
ConditionVascular Access Device
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorTeleflex
About this trial
The general objective of Teleflex's Vascular Access Device Registry (VADER) is to provide high-quality Level 3 (or better) data on the performance, safety and clinical benefits of Teleflex's vascular access devices when used in a real-world setting
Eligibility criteria
Qualifiers
Subjects will undergo a procedure that will include use of a Teleflex device covered by this Research.
Subject is willing and capable of providing informed consent and/or give approval to collect, store and process limited health information by the Sponsor; or such consent is provided by a legally designated representative if required by local law or regulation.
Subjects is able to read and understand English or Spanish languages
Disqualifiers
Subject is currently participating in another clinical Registry or investigation that may confound the results of this Registry.
Subject was previously failed screening or was enrolled in this clinical Registry.
Subject is imprisoned
Subject is cognitively impaired and unable to provide informed consent
Trial design
Treatments tested in this trial
- Central venous catheter
Treatment groups
2,500 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov